First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders
Clinical trial NCT02702648 · COMPLETED
Trial details
- NCT number
- NCT02702648
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-03-06
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.